ARC-520 produces deep and durable knockdown of viral antigens and DNA in a phase II study in patients with chronic hepatitis B Yuen, M., Chan, H., Liu, S., Given, B., Schluep, T., Hamilton, J., Lai, C., Locarnini, S., Lau, J. Y., Ferrari, C., Gish, R. WILEY. 2015: 1385A

View details for Web of Science ID 000367013200010